Nisha Unni

机构：Parkland Health & Hospital System, Southwestern Medical Center, Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center · ORCID：0000-0003-1549-4720

发表论文 97 篇 · 总被引 905 次 · h-index 13

代表论文

• CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer (2025 · Journal of Clinical Investigation · 被引 5)
• Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen (2026 · Breast Cancer Research and Treatment · 被引 1)
• Event-free survival from the randomized phase 2 neoHIP trial evaluating neoadjuvant taxane, HER2-targeted therapy, +/- pembrolizumab in early-stage HER2-positive breast cancer. (2026 · Journal of Clinical Oncology · 被引 1)
• Efficacy and Genomic Analysis of HER2 -Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial (2026 · Clinical Cancer Research · 被引 1)
• Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core (2025 · The Prostate · 被引 1)
• Early Prediction of the Breast Cancer Response to Neoadjuvant Chemotherapy Based on Intratumoral Interstitial Fluid Pressure using 3-D Subharmonic-Aided Pressure Estimation (2026 · Ultrasound in Medicine & Biology)